HealthEquity, Inc.
NASDAQ:HQYMedical - Healthcare Information Services
-$0.54 today
- Market cap
- $8.05B
- Beta
- 0.21
- P/E (TTM)
- 31.4
- EPS (TTM)
- $2.73
Volume 1.29M
Average 0.98M
HQY Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
HealthEquity, Inc.NASDAQ: HQY
Other Current Liabilities · Q2 FY2027 · quarter ended Jul 2026
Other current liabilities rises 109.5% from a year ago
Other current liabilities stood at $135.21M at the end of Q2 FY2027, up 109.5% from a year earlier and up 407.1% from the prior quarter. Over 3 fiscal years it compounded at +9.6% a year.
Context
- Other current liabilities amounted to 4.1% of total assets at the end of Q2 FY2027, up 2.2 pp from a year earlier.
- Other current liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether other current liabilities keeps rising in the next quarterly balance sheet after a +109.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2026
- 60.39M USD
- Year-over-year change
- -12.9%
- 4-year CAGR
- +6.4%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 60.39M | -12.9% |
| FY2025 | 2025-01-31 | 69.33M | +39.8% |
| FY2024 | 2024-01-31 | 49.61M | +8.2% |
| FY2023 | 2023-01-31 | 45.84M | -2.8% |
| FY2022 | 2022-01-31 | 47.14M | — |
Other Current Liabilities vs competitors
How HQY compares with its peers on the latest reported figures
- HQY's Jul 2026 other current liabilities of $135.21M is the 2nd highest of the 8 companies compared; the peer median is $31.23M.
- Its year-over-year change of +109.5% is the 5th highest of 7, against a peer median of +182.8%.
- Other current liabilities amounts to 4.1% of total assets for HQY, versus a peer median of 7.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $139.86M | +203.5% | -8.0% | 7.0% | |
| Jul 2026 | $135.21M | +109.5% | +9.6% | 4.1% | |
CTEVClaritev Corporation | Mar 2026 | $110.79M | +408.7% | +73.8% | 2.3% |
| Apr 2026 | $94.29M | +3082.4% | +30.4% | 14.2% | |
| Mar 2026 | $31.23M | — | +59.3% | 10.3% | |
| Jun 2026 | $26.02M | +13.4% | +16.7% | 0.4% | |
| Mar 2026 | $19.56M | -28.7% | -1.2% | 6.0% | |
| Mar 2026 | $7.63M | +162.0% | -15.9% | 8.8% | |
| Peer median (excluding HQY) | $31.23M | +182.8% | +16.7% | 7.0% | |
Competitors are the stored peer set for HQY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 225.41M | 254.27M | 403.98M | 295.95M | 318.93M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 87.43M | 96.84M | 104.89M | 118.01M | 123.7M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 38.5M | 31.79M | 48.56M | 63.8M | 69.66M |
| Total Current Assets | 351.34M | 382.89M | 557.44M | 477.75M | 512.28M |
| Property, Plant & Equipment (Net) | 86.99M | 69.32M | 54.39M | 46.42M | 39.49M |
| Goodwill | 1.65B | 1.65B | 1.65B | 1.65B | 1.65B |
| Intangible Assets | 973.14M | 936.36M | 835.95M | 1.2B | 1.1B |
| Long-term Investments | 0 | 0 | 0 | 0 | 3.29M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 49.81M | 52.18M | 67.87M | 71.57M | 131.67M |
| Total Non-current Assets | 2.76B | 2.71B | 2.61B | 2.97B | 2.92B |
| Total Assets | 3.11B | 3.09B | 3.16B | 3.45B | 3.43B |
| Account Payables | 27.54M | 13.9M | 12.04M | 14.36M | 12.16M |
| Short-term Debt | 8.75M | 17.5M | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 47.14M | 45.84M | 49.61M | 69.33M | 60.39M |
| Total Current Liabilities | 153.19M | 131.06M | 117.09M | 156.32M | 156.85M |
| Long-term Debt | 922.08M | 907.84M | 874.97M | 1.06B | 957.38M |
| Deferred Tax Liabilities | 99.85M | 82.67M | 68.67M | 55.83M | 145.42M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 14.19M | 12.71M | 19.27M | 22.96M | 31.01M |
| Total Non-current Liabilities | 1.1B | 1.06B | 1.01B | 1.18B | 1.17B |
| Total Liabilities | 1.25B | 1.19B | 1.13B | 1.33B | 1.32B |
| Common Stock | 8K | 8K | 9K | 9K | 8K |
| Retained Earnings | 176.06M | 149.92M | 205.63M | 209.27M | 195.91M |
| Accumulated OCI | 0 | 0 | 0 | 0 | (5.71M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.85B | 1.9B | 2.04B | 2.11B | 2.11B |
| Total Debt | 1.01B | 994.49M | 933.14M | 1.11B | 1B |
| Net Debt | 782.82M | 740.22M | 529.16M | 812.57M | 682.55M |
HealthEquity, Inc.
NASDAQ:HQY
Intrinsic Alpha fair value
Locked
Current Price
$97.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.